Efficacy evaluation of Der p 1 DNA vaccine for allergic asthma in an experimental mouse model

Vaccine

Volumn 24, Issue 21, 2006, Pages 4576-4581

  HuangFu, TaoQi ^a   Lim, Lay Hong ^a   Chua, Kaw Yan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Der p 1; DNA vaccine; Naked DNA

Indexed keywords

DER P 1 VACCINE; DNA VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN KAPPA CHAIN; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULINS; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 33646827686     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.028     Document Type: Article

References (14)

1. Weiss K.B., Sullivan S.D., and Lyttle C.S. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 106 (2000) 493-499
2. Silvestri M., Rossi G.A., Cozzani S., Pulvirenti G., and Fasce L. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 83 (1999) 335-340
3. Chua K.Y., Stewart G.A., Thomas W.R., Simpson R.J., Dilworth R.J., Plozza T.M., et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J Exp Med 167 1 (1988) 175-182
4. Wolfowicz C.B., HuangFu T., and Chua K.Y. Expression and immunogenicity of the major house dust mite allergen Der p 1 following DNA immunization. Vaccine 21 (2003) 1195-1204
5. Schulz O., Sewell H.F., and Shakib F. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 187 2 (1998) 271-275
6. Wany H., Winton H.L., Soeller C., Tovey E.R., Guenert D.C., Thompson P.J., et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104 1 (1999) 123-133
7. Massaer M., Mazzu P., Haumont M., Magi M., Daminet V., Bollen A., et al. High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage. Int Arch Allergy Immunol 125 (2001) 32-43
8. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
9. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156 (1997) 766-775
10. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
11. Cohn L., Elias J.A., and Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22 (2004) 789-815
12. Jarman E.R., and Lamb J.R. Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling. Immunology 112 4 (2004) 631-642
13. Bauer R., Himly M., Dedic A., Ferreira F., Thalhamer J., and Hartl A. Optimization of codon usage increased immunogenicity of DNA vaccination of a major plant allergen in mice. Allergy 58 (2003) 1003-1010
14. Kwon S.S., Kim N., and Yoo T.J. The effect of vaccination with DNA encoding murine T-cell epitopes on the Der p 1 and 2 induced immunoglobulin E synthesis. Allergy 56 8 (2001) 741-748